Clinical trial delays are rapidly increasing, resulting in costly financial losses for sponsors. It is more important than ever to understand the drivers of delays, and take preventative action.
In this whitepaper, we draw on recent literature and reviews of common reasons for protocol amendments, as well as our own 20+ years of experience in successfully supporting more than 1,500 studies with insights and recruitment, with an overall first-time EC approval rate of 96%.
More specifically, this whitepaper covers:
- The 4 main causes of delays, and how to overcome them
- How flexible recruitment strategies can adapt to disruptions and protocol amendments
- Why referral tracking and accountability are important in avoiding delays, and improving recruitment and retention
